nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0669	0.126	CbGbCtD
Paricalcitol—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0629	0.119	CbGbCtD
Paricalcitol—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0629	0.119	CbGbCtD
Paricalcitol—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0569	0.107	CbGbCtD
Paricalcitol—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0569	0.107	CbGbCtD
Paricalcitol—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0491	0.0925	CbGbCtD
Paricalcitol—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0476	0.0898	CbGbCtD
Paricalcitol—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0431	0.0812	CbGbCtD
Paricalcitol—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0431	0.0812	CbGbCtD
Paricalcitol—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0413	0.0779	CbGbCtD
Paricalcitol—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.0118	0.208	CbGeAlD
Paricalcitol—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.00454	0.0801	CbGeAlD
Paricalcitol—CYP24A1—digestive system—acquired immunodeficiency syndrome	0.00454	0.0801	CbGeAlD
Paricalcitol—UGT1A4—blood—acquired immunodeficiency syndrome	0.00432	0.0764	CbGeAlD
Paricalcitol—CYP24A1—vagina—acquired immunodeficiency syndrome	0.00401	0.0708	CbGeAlD
Paricalcitol—CYP24A1—lung—acquired immunodeficiency syndrome	0.00379	0.0669	CbGeAlD
Paricalcitol—VDR—skin of body—acquired immunodeficiency syndrome	0.00312	0.0552	CbGeAlD
Paricalcitol—VDR—lymphoid tissue—acquired immunodeficiency syndrome	0.00253	0.0447	CbGeAlD
Paricalcitol—VDR—digestive system—acquired immunodeficiency syndrome	0.0025	0.0441	CbGeAlD
Paricalcitol—VDR—blood—acquired immunodeficiency syndrome	0.00238	0.042	CbGeAlD
Paricalcitol—VDR—bone marrow—acquired immunodeficiency syndrome	0.0023	0.0407	CbGeAlD
Paricalcitol—VDR—vagina—acquired immunodeficiency syndrome	0.00221	0.039	CbGeAlD
Paricalcitol—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00217	0.0384	CbGeAlD
Paricalcitol—VDR—lung—acquired immunodeficiency syndrome	0.00209	0.0369	CbGeAlD
Paricalcitol—VDR—lymph node—acquired immunodeficiency syndrome	0.00143	0.0252	CbGeAlD
Paricalcitol—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000835	0.0148	CbGeAlD
Paricalcitol—CYP3A4—blood—acquired immunodeficiency syndrome	0.000796	0.0141	CbGeAlD
Paricalcitol—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000646	0.0114	CbGeAlD
Paricalcitol—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000622	0.011	CbGeAlD
Paricalcitol—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.000662	CcSEcCtD
Paricalcitol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.000662	CcSEcCtD
Paricalcitol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000273	0.000662	CcSEcCtD
Paricalcitol—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000272	0.00066	CcSEcCtD
Paricalcitol—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.00066	CcSEcCtD
Paricalcitol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.000659	CcSEcCtD
Paricalcitol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.000657	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.000657	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00027	0.000655	CcSEcCtD
Paricalcitol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00027	0.000654	CcSEcCtD
Paricalcitol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00027	0.000654	CcSEcCtD
Paricalcitol—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.000654	CcSEcCtD
Paricalcitol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.000654	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.000653	CcSEcCtD
Paricalcitol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000653	CcSEcCtD
Paricalcitol—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.000652	CcSEcCtD
Paricalcitol—Pain—Indinavir—acquired immunodeficiency syndrome	0.000268	0.000649	CcSEcCtD
Paricalcitol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000268	0.000649	CcSEcCtD
Paricalcitol—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000268	0.000648	CcSEcCtD
Paricalcitol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000268	0.000648	CcSEcCtD
Paricalcitol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.000647	CcSEcCtD
Paricalcitol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.000646	CcSEcCtD
Paricalcitol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.000645	CcSEcCtD
Paricalcitol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.000645	CcSEcCtD
Paricalcitol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000266	0.000644	CcSEcCtD
Paricalcitol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.000644	CcSEcCtD
Paricalcitol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000644	CcSEcCtD
Paricalcitol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000265	0.000642	CcSEcCtD
Paricalcitol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000265	0.000642	CcSEcCtD
Paricalcitol—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.000641	CcSEcCtD
Paricalcitol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.000641	CcSEcCtD
Paricalcitol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00064	CcSEcCtD
Paricalcitol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00064	CcSEcCtD
Paricalcitol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.000639	CcSEcCtD
Paricalcitol—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.000639	CcSEcCtD
Paricalcitol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.000637	CcSEcCtD
Paricalcitol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.000637	CcSEcCtD
Paricalcitol—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.000637	CcSEcCtD
Paricalcitol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000263	0.000637	CcSEcCtD
Paricalcitol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.000635	CcSEcCtD
Paricalcitol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.000634	CcSEcCtD
Paricalcitol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000261	0.000633	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.000632	CcSEcCtD
Paricalcitol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.000631	CcSEcCtD
Paricalcitol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.000629	CcSEcCtD
Paricalcitol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.000627	CcSEcCtD
Paricalcitol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000258	0.000625	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.000625	CcSEcCtD
Paricalcitol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000624	CcSEcCtD
Paricalcitol—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000257	0.000623	CcSEcCtD
Paricalcitol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.000623	CcSEcCtD
Paricalcitol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.000623	CcSEcCtD
Paricalcitol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000257	0.000623	CcSEcCtD
Paricalcitol—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000622	CcSEcCtD
Paricalcitol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000256	0.000621	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00062	CcSEcCtD
Paricalcitol—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000256	0.00062	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.000619	CcSEcCtD
Paricalcitol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000255	0.000618	CcSEcCtD
Paricalcitol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000255	0.000618	CcSEcCtD
Paricalcitol—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.000616	CcSEcCtD
Paricalcitol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.000616	CcSEcCtD
Paricalcitol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.000616	CcSEcCtD
Paricalcitol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.000613	CcSEcCtD
Paricalcitol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.000613	CcSEcCtD
Paricalcitol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000253	0.000613	CcSEcCtD
Paricalcitol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000253	0.000613	CcSEcCtD
Paricalcitol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000253	0.000612	CcSEcCtD
Paricalcitol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000612	CcSEcCtD
Paricalcitol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000252	0.000612	CcSEcCtD
Paricalcitol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.000611	CcSEcCtD
Paricalcitol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.00061	CcSEcCtD
Paricalcitol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000251	0.000609	CcSEcCtD
Paricalcitol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.000608	CcSEcCtD
Paricalcitol—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.000608	CcSEcCtD
Paricalcitol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.000608	CcSEcCtD
Paricalcitol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.000607	CcSEcCtD
Paricalcitol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.000605	CcSEcCtD
Paricalcitol—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.000605	CcSEcCtD
Paricalcitol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000604	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.000603	CcSEcCtD
Paricalcitol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000249	0.000603	CcSEcCtD
Paricalcitol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.000601	CcSEcCtD
Paricalcitol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.0006	CcSEcCtD
Paricalcitol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000248	0.0006	CcSEcCtD
Paricalcitol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000248	0.0006	CcSEcCtD
Paricalcitol—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000599	CcSEcCtD
Paricalcitol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.000599	CcSEcCtD
Paricalcitol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000246	0.000597	CcSEcCtD
Paricalcitol—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000246	0.000596	CcSEcCtD
Paricalcitol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.000594	CcSEcCtD
Paricalcitol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000245	0.000594	CcSEcCtD
Paricalcitol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000245	0.000593	CcSEcCtD
Paricalcitol—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.000593	CcSEcCtD
Paricalcitol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.000593	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000592	CcSEcCtD
Paricalcitol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000244	0.000592	CcSEcCtD
Paricalcitol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000244	0.000591	CcSEcCtD
Paricalcitol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000244	0.000591	CcSEcCtD
Paricalcitol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000591	CcSEcCtD
Paricalcitol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000244	0.00059	CcSEcCtD
Paricalcitol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000244	0.00059	CcSEcCtD
Paricalcitol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000243	0.000588	CcSEcCtD
Paricalcitol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000243	0.000588	CcSEcCtD
Paricalcitol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.000587	CcSEcCtD
Paricalcitol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.000587	CcSEcCtD
Paricalcitol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000242	0.000587	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.000586	CcSEcCtD
Paricalcitol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000242	0.000585	CcSEcCtD
Paricalcitol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000241	0.000583	CcSEcCtD
Paricalcitol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00024	0.000583	CcSEcCtD
Paricalcitol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.000582	CcSEcCtD
Paricalcitol—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000582	CcSEcCtD
Paricalcitol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000239	0.000579	CcSEcCtD
Paricalcitol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.000579	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000578	CcSEcCtD
Paricalcitol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.000577	CcSEcCtD
Paricalcitol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.000577	CcSEcCtD
Paricalcitol—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000237	0.000574	CcSEcCtD
Paricalcitol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.000573	CcSEcCtD
Paricalcitol—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000571	CcSEcCtD
Paricalcitol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00057	CcSEcCtD
Paricalcitol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.00057	CcSEcCtD
Paricalcitol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000235	0.00057	CcSEcCtD
Paricalcitol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000567	CcSEcCtD
Paricalcitol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.000567	CcSEcCtD
Paricalcitol—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.000566	CcSEcCtD
Paricalcitol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000566	CcSEcCtD
Paricalcitol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000233	0.000565	CcSEcCtD
Paricalcitol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000564	CcSEcCtD
Paricalcitol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000563	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000561	CcSEcCtD
Paricalcitol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.000559	CcSEcCtD
Paricalcitol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000559	CcSEcCtD
Paricalcitol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.000558	CcSEcCtD
Paricalcitol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00023	0.000558	CcSEcCtD
Paricalcitol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00023	0.000558	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000556	CcSEcCtD
Paricalcitol—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000555	CcSEcCtD
Paricalcitol—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000228	0.000552	CcSEcCtD
Paricalcitol—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000551	CcSEcCtD
Paricalcitol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000227	0.000549	CcSEcCtD
Paricalcitol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.000548	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000548	CcSEcCtD
Paricalcitol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000547	CcSEcCtD
Paricalcitol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000225	0.000545	CcSEcCtD
Paricalcitol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000225	0.000544	CcSEcCtD
Paricalcitol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000544	CcSEcCtD
Paricalcitol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000544	CcSEcCtD
Paricalcitol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000543	CcSEcCtD
Paricalcitol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000542	CcSEcCtD
Paricalcitol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000224	0.000542	CcSEcCtD
Paricalcitol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000542	CcSEcCtD
Paricalcitol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.000542	CcSEcCtD
Paricalcitol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000223	0.00054	CcSEcCtD
Paricalcitol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000537	CcSEcCtD
Paricalcitol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000222	0.000537	CcSEcCtD
Paricalcitol—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000219	0.000531	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.000531	CcSEcCtD
Paricalcitol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000528	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000527	CcSEcCtD
Paricalcitol—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000527	CcSEcCtD
Paricalcitol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000217	0.000526	CcSEcCtD
Paricalcitol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000523	CcSEcCtD
Paricalcitol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000523	CcSEcCtD
Paricalcitol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000522	CcSEcCtD
Paricalcitol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000216	0.000522	CcSEcCtD
Paricalcitol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000519	CcSEcCtD
Paricalcitol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000519	CcSEcCtD
Paricalcitol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000519	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000519	CcSEcCtD
Paricalcitol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000518	CcSEcCtD
Paricalcitol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.000514	CcSEcCtD
Paricalcitol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000514	CcSEcCtD
Paricalcitol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000212	0.000514	CcSEcCtD
Paricalcitol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000513	CcSEcCtD
Paricalcitol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.000511	CcSEcCtD
Paricalcitol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000507	CcSEcCtD
Paricalcitol—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000506	CcSEcCtD
Paricalcitol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000505	CcSEcCtD
Paricalcitol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000504	CcSEcCtD
Paricalcitol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000503	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000503	CcSEcCtD
Paricalcitol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000502	CcSEcCtD
Paricalcitol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000207	0.000502	CcSEcCtD
Paricalcitol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000501	CcSEcCtD
Paricalcitol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000501	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000499	CcSEcCtD
Paricalcitol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000498	CcSEcCtD
Paricalcitol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000498	CcSEcCtD
Paricalcitol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000492	CcSEcCtD
Paricalcitol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000491	CcSEcCtD
Paricalcitol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000485	CcSEcCtD
Paricalcitol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000485	CcSEcCtD
Paricalcitol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.000485	CcSEcCtD
Paricalcitol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000483	CcSEcCtD
Paricalcitol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000483	CcSEcCtD
Paricalcitol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000482	CcSEcCtD
Paricalcitol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.00048	CcSEcCtD
Paricalcitol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000478	CcSEcCtD
Paricalcitol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000478	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000476	CcSEcCtD
Paricalcitol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000196	0.000475	CcSEcCtD
Paricalcitol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.000474	CcSEcCtD
Paricalcitol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000469	CcSEcCtD
Paricalcitol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000467	CcSEcCtD
Paricalcitol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000463	CcSEcCtD
Paricalcitol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.00046	CcSEcCtD
Paricalcitol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.00046	CcSEcCtD
Paricalcitol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000456	CcSEcCtD
Paricalcitol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000455	CcSEcCtD
Paricalcitol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000454	CcSEcCtD
Paricalcitol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000452	CcSEcCtD
Paricalcitol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000452	CcSEcCtD
Paricalcitol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000451	CcSEcCtD
Paricalcitol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.00045	CcSEcCtD
Paricalcitol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000449	CcSEcCtD
Paricalcitol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000449	CcSEcCtD
Paricalcitol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000438	CcSEcCtD
Paricalcitol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000436	CcSEcCtD
Paricalcitol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000434	CcSEcCtD
Paricalcitol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000432	CcSEcCtD
Paricalcitol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000432	CcSEcCtD
Paricalcitol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000432	CcSEcCtD
Paricalcitol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00043	CcSEcCtD
Paricalcitol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000429	CcSEcCtD
Paricalcitol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000426	CcSEcCtD
Paricalcitol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000419	CcSEcCtD
Paricalcitol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000418	CcSEcCtD
Paricalcitol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000418	CcSEcCtD
Paricalcitol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000412	CcSEcCtD
Paricalcitol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000407	CcSEcCtD
Paricalcitol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000404	CcSEcCtD
Paricalcitol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000403	CcSEcCtD
Paricalcitol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.0004	CcSEcCtD
Paricalcitol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.0004	CcSEcCtD
Paricalcitol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000398	CcSEcCtD
Paricalcitol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000397	CcSEcCtD
Paricalcitol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000388	CcSEcCtD
Paricalcitol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000385	CcSEcCtD
Paricalcitol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000385	CcSEcCtD
Paricalcitol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000385	CcSEcCtD
Paricalcitol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000382	CcSEcCtD
Paricalcitol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000377	CcSEcCtD
Paricalcitol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.00037	CcSEcCtD
Paricalcitol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000367	CcSEcCtD
Paricalcitol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000367	CcSEcCtD
Paricalcitol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000365	CcSEcCtD
Paricalcitol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000363	CcSEcCtD
Paricalcitol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000346	CcSEcCtD
